Drug Type CAR-NK |
Synonyms AntiROR1 NK cell therapy, CARNK cell therapy against ROR1 |
Target |
Mechanism ROR1 antagonists(Inactive tyrosine-protein kinase transmembrane receptor ROR1 antagonists), Immunologic cytotoxicity, Natural killer cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | SE | - | |
Neoplasms | Preclinical | US | - | |
Neoplasms | Preclinical | US | - | |
Neoplasms | Preclinical | SE | - |